58Indexed trials
mesh condition
Neurodegenerative Diseases
Intelligence
Neurodegenerative Diseases intelligence: 58 indexed trials, 23 recruiting studies, 52 sponsors across 47 countries.
23Recruiting
52Sponsors
47Countries
Leading sponsors
Novartis30 recruiting
Avid Radiopharmaceuticals20 recruiting
Novartis Pharmaceuticals21 recruiting
University Medical Center Groningen20 recruiting
Tammie L. S. Benzinger, MD, PhD21 recruiting
Chinese University of Hong Kong10 recruiting
Center for Eye Research Australia11 recruiting
Azienda Sanitaria Universitaria Integrata del Trentino11 recruiting
Eli Lilly and Company11 recruiting
Eisai Limited10 recruiting
Elizabeth K Rhodus10 recruiting
Beijing Friendship Hospital10 recruiting
Geographic activity
United States18trials
France14trials
United Kingdom12trials
Canada10trials
Germany10trials
Italy10trials
Spain9trials
Netherlands8trials
Australia8trials
China6trials
Austria4trials
South Korea4trials
Leading interventions
CAD1063trials
E20202trials
F 18 T8072trials
Active patterned repetitive transcranial magnetic stimulation (prTMS)1trials
Blood sampling1trials
Blood sampling, skin biopsy1trials
Biosample collection.1trials
Brain Magnetic Resonance Imaging (MRI)1trials
Clinical characteristics of AMS patients1trials
Crenezumab1trials
Curcumin and ginkgo extract1trials
Auditory stimulation1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.